Development of a novel drug for treating opioid use disorder

Ended Cooperative Agreement Awarded Last action

Award ID
UG3DA048234
Recipient
Awarding agency
Obligated
$6,611,614

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding
  • $6,447,482.00 Federal
  • $164,132.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $164,132 $0
Amendment $164,132 $164,132
Amendment $0 $0
Amendment $0 $0
Amendment $3,058,678 $0
Amendment $0 $0
Amendment $0 $0
Original award $3,060,540 $0
Show all 17

Quick answers

Who received award UG3DA048234?

UG3DA048234 was awarded to Nirsum Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 15, 2019.

How much is award UG3DA048234 worth?

$6,611,614 has been obligated on UG3DA048234: $6,447,482 in federal funding and $164,132 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award